About this trial
Periodontitis is considered a focus of infection where oral bacteria, bacterial by-products or inflammatory mediators can interact with other parts of the organism via the blood. Periodontal pathogen components such as DNA, RNA or specific antigens of P. gingivalis, Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Treponema denticola (T. denticola), Fusobacterium nucleatum (F. nucleatum) or Campylobacter rectus have been isolated from different tissues such as atheroma plaques, placenta, amniotic sac and respiratory tract. It has been reported that periodontitis may contribute to endothelial dysfunction leading to the formation of atherosclerosis.
Eligibility criteria
Qualifiers
Diagnosed with endarterectomy
Not receiving chemotherapy
Not having received this treatment before
Disqualifiers
Having systemic infection
Patients with severe heart disease
Trial design
Treatments tested in this trial
- atheroma plaque
- dental plaque